Key Record Dates Identifier: NCT04442737
Brief Title: A Study of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight Gain (DEFINE)

First Submitted : June 3, 2020
First Submitted that Met QC Criteria : June 18, 2020
First Posted : June 23, 2020

Last Update Submitted that Met QC Criteria : May 11, 2021
Last Update Posted : May 12, 2021